Welcome to LookChem.com Sign In|Join Free

CAS

  • or

373-49-9

Post Buying Request

373-49-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

373-49-9 Usage

Description

Palmitoleic acid, also known as (Z)-9-hexadecenoic acid, is an omega-7 monounsaturated fatty acid with the formula CH3(CH2)5CH=CH(CH2)7COOH. It is a common constituent of the glycerides in human adipose tissue and is present in all tissues, with higher concentrations found in the liver. Palmitoleic acid is biosynthesized from palmitic acid by the action of the enzyme delta-9 desaturase. It is a beneficial fatty acid that has been shown to increase insulin sensitivity by suppressing inflammation and inhibiting the destruction of insulin-secreting pancreatic beta cells. It is found in various dietary sources, including animal oils, vegetable oils, and marine oils, with macadamia oil and sea buckthorn oil being botanical sources with high concentrations.

Uses

1. Used in Dietary Supplements:
Palmitoleic acid is used as a dietary supplement for reducing protein oxidation in mammals.
2. Used in Organic Synthesis:
Palmitoleic acid is utilized in organic synthesis processes.
3. Used in Chromatographic Analysis:
Palmitoleic acid serves as a standard in chromatographic analysis.
4. Used in Pharmaceutical Industry:
As a beneficial fatty acid, palmitoleic acid has potential applications in the pharmaceutical industry for developing treatments related to insulin sensitivity and inflammation.
5. Used in Food Industry:
Given its presence in various oils and its beneficial properties, palmitoleic acid can be used in the food industry for the development of health-promoting products.
6. Used in Cosmetics Industry:
Due to its presence in human adipose tissue and its potential health benefits, palmitoleic acid may also find applications in the cosmetics industry for products targeting skin health and inflammation reduction.

Biochem/physiol Actions

Palmitoleic acid is a 16-carbon, omega-7, monounsaturated fatty acid that is enriched in the triglycerides of human adipose tissue and in liver.

Check Digit Verification of cas no

The CAS Registry Mumber 373-49-9 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,7 and 3 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 373-49:
(5*3)+(4*7)+(3*3)+(2*4)+(1*9)=69
69 % 10 = 9
So 373-49-9 is a valid CAS Registry Number.
InChI:InChI=1/C16H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h7-8H,2-6,9-15H2,1H3,(H,17,18)/b8-7-

373-49-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name palmitoleic acid

1.2 Other means of identification

Product number -
Other names cis-9-Hexadecenoic Acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Adhesives and sealant chemicals,Agricultural chemicals (non-pesticidal),Finishing agents,Lubricants and lubricant additives,Surface active agents
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:373-49-9 SDS

373-49-9Relevant articles and documents

Maternal obesity results in decreased syncytiotrophoblast synthesis of palmitoleic acid, a fatty acid with anti-inflammatory and insulin-sensitizing properties

Barner, Kelsey,Ferchaud-Roucher, Véronique,Jansson, Thomas,Powell, Theresa L.

, p. 6643 - 6654 (2020/02/28)

The fetus is dependent on delivery of fatty acids (FAs) by the syncytiotrophoblast, the transporting epithelium of the human placenta. Obese pregnant women have dyslipidemia; however, whether obesity impacts placental lipid transport and metabolism remains to be fully established. Palmitoleic acid (POA), an FA with antiinflammatory and insulin-sensitizing properties, is synthesized from palmitic acid (PA) catalyzed by stearoyl-coenzyme A desaturase (SCD) activity. We hypothesized that the uptake and incorporation of FAs and POA synthesis are reduced in primary human trophoblasts (PHTs) isolated from pregnancies complicated by maternal obesity. Villous cytotrophoblasts were isolated from 7 placentas of obese [body mass index (BMI) = 37.5 ± 1.9] and 12 normal (BMI = 23.6 ± 0.6) mothers. FA uptake and incorporation were assessed using uniformly labeled (U[13C])–FA mixtures of PA, oleic acid (OA), linoleic acid, and docosahexaenoic acid. Cellular [13C] FAs were quantified both in total cellular lipids and in lipid classes by GC-MS. Uptake and incorporation of [13C] FAs in total cellular lipids were not different in PHTs isolated from obese mothers compared with normal mothers. Only the concentration of OA was increased in the triglyceride fraction (P 13C]-PA treatment, demonstrating SCD activity in PHT cells. Labeled POA content and the POA:PA ratio were significantly lower in PHTs isolated from placentas of obese mothers compared with normal, healthy controls. Decreased syncytiotrophoblast POA synthesis may contribute to insulin resistance and low-grade inflammation in the mother, placenta, or fetus (or a combination of the 3) in pregnancies complicated by obesity.—Ferchaud-Roucher, V., Barner, K., Jansson, T., Powell, T. L. Maternal obesity results in decreased syncytiotrophoblast synthesis of palmitoleic acid, a fatty acid with anti-inflammatory and insulin-sensitizing properties. FASEB J. 33, 6643–6654 (2019). www.fasebj.org.

Synthesis and Characterization of Novel Acyl-Glycine Inhibitors of GlyT2

Mostyn, Shannon N.,Carland, Jane E.,Shimmon, Susan,Ryan, Renae M.,Rawling, Tristan,Vandenberg, Robert J.

, p. 1949 - 1959 (2017/09/26)

It has been demonstrated previously that the endogenous compound N-arachidonyl-glycine inhibits the glycine transporter GlyT2, stimulates glycinergic neurotransmission, and provides analgesia in animal models of neuropathic and inflammatory pain. However, it is a relatively weak inhibitor with an IC50 of 9 μM and is subject to oxidation via cyclooxygenase, limiting its therapeutic value. In this paper we describe the synthesis and testing of a novel series of monounsaturated C18 and C16 acyl-glycine molecules as inhibitors of the glycine transporter GlyT2. We demonstrate that they are up to 28 fold more potent that N-arachidonyl-glycine with no activity at the closely related GlyT1 transporter at concentrations up to 30 μM. This novel class of compounds show considerable promise as a first generation of GlyT2 transport inhibitors.

ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS

-

Page/Page column 25-26, (2012/05/20)

Esteramine compositions and their derivatives are disclosed. The esteramines comprise a reaction product of a metathesis-derived C10-C17 monounsaturated acid, octadecene-1,18-dioic acid, or their ester derivatives with a tertiary alkanolamine. Derivatives made by quaternizing, sulfonating, alkoxylating, sulfating, and/or sulfitating the esteramines are also disclosed. In one aspect, the ester derivative of the C10-C17 monounsaturated acid or octadecene-1,18-dioic acid is a lower alkyl ester. In other aspects, the ester derivative is a modified triglyceride made by self-metathesis of a natural oil or an unsaturated triglyceride made by cross-metathesis of a natural oil with an olefin. The esteramines and derivatives are valuable for a wide variety of end uses, including cleaners, fabric treatment, hair conditioning, personal care (liquid cleansing products, conditioning bars, oral care products), antimicrobial compositions, agricultural uses, and oil field applications.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 373-49-9